Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

WINDTREE THERAPEUTICS INC /DE/

CIK 946486 WINT·Biological Products · All EDGAR filings ↗

Late filing elevated Filing comparison

WINDTREE THERAPEUTICS INC /DE/ told the SEC it could not file its annual report on time

Does not expect a significant change in results. 1 day past the statutory due date.

As reported in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, our existing resources are limited. In response to our limited liquidity, the Company is seeking sources of capital through potential strategic transactions. The Company management has devoted significant resources toward finalizing its financial statements and disclosures, however, the Company was required to devote a significant amount of time and other Company resources to other matters such as financing opportunities, which normally would be devoted to the preparation of the Annual Report on Form 10-K (the “Form 10-K”) and related matters. There can be no assurance that a strategic…
Evidence
Anticipates significant change
No
Days past due date
1
Other periodic reports filed
Yes
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
As reported in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, our existing resources are limited. In response to our limited liquidity, the Company is seeking sources of capital through potential strategic transactions. The Company management has devoted significant resources toward finalizing its financial statements and disclosures, however, the Company was required to devote a significant amount of time and other Company resources to other matters such as financing opportunities, which normally would be devoted to the preparation of the Annual Report on Form 10-K (the “Form 10-K”) and related matters. There can be no assurance that a strategic…
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.